These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8407756)

  • 1. Fluoxetine and memory impairment.
    Bradley SJ; Kulik L
    J Am Acad Child Adolesc Psychiatry; 1993 Sep; 32(5):1078-9. PubMed ID: 8407756
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluoxetine and memory impairment.
    Friedman EH
    J Am Acad Child Adolesc Psychiatry; 1994 Jun; 33(5):763. PubMed ID: 8056743
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluoxetine treatment of obsessive-compulsive disorder: an open clinical trial.
    Liebowitz MR; Hollander E; Schneier F; Campeas R; Hatterer J; Papp L; Fairbanks J; Sandberg D; Davies S; Stein M
    J Clin Psychopharmacol; 1989 Dec; 9(6):423-7. PubMed ID: 2687337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorder.
    Fontaine R; Chouinard G
    J Clin Psychopharmacol; 1986 Apr; 6(2):98-101. PubMed ID: 3517083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine and suicidal ideation.
    Koizumi H
    J Am Acad Child Adolesc Psychiatry; 1991 Jul; 30(4):695. PubMed ID: 1890110
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluoxetine treatment of obsessive-compulsive disorder.
    Turner SM; Jacob RG; Beidel DC; Himmelhoch J
    J Clin Psychopharmacol; 1985 Aug; 5(4):207-12. PubMed ID: 3894437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.
    Tollefson GD; Birkett M; Koran L; Genduso L
    J Clin Psychiatry; 1994 Oct; 55 Suppl():69-76; discussion 77-8. PubMed ID: 7961535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse cutaneous reactions associated with fluoxetine strategy for reintroduction of this drug in selected patients.
    Leznoff A; Binkley KE; Joffee RT; Levitt A; Richter MA
    J Clin Psychopharmacol; 1992 Oct; 12(5):355-7. PubMed ID: 1479054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
    Simeon JG; Thatte S; Wiggins D
    Psychopharmacol Bull; 1990; 26(3):285-90. PubMed ID: 2274627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of long-term fluoxetine treatment of obsessive-compulsive disorder.
    Frenkel A; Rosenthal J; Nezu A; Winston A
    Mt Sinai J Med; 1990 Nov; 57(6):348-52. PubMed ID: 2079952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fluoxetine-induced frontal lobe syndrome in an obsessive compulsive patient.
    Hoehn-Saric R; Harris GJ; Pearlson GD; Cox CS; Machlin SR; Camargo EE
    J Clin Psychiatry; 1991 Mar; 52(3):131-3. PubMed ID: 2005077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacotoxic psychosis and extrapyramidal motor syndrome. A case of acute adverse effect of fluoxetine and flupenthixol].
    Pach J
    Nervenarzt; 1992 Sep; 63(9):575-6. PubMed ID: 1407229
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis and fluoxetine treatment of compulsive behavior disorder of adults with mental retardation.
    Bodfish JW; Madison JT
    Am J Ment Retard; 1993 Nov; 98(3):360-7. PubMed ID: 8292312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
    Riddle MA; Scahill L; King RA; Hardin MT; Anderson GM; Ort SI; Smith JC; Leckman JF; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1062-9. PubMed ID: 1429406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine and neuroleptic synergistic effects.
    Matthews P; Quinn D; Marcoux GS; Falkenberg K
    J Am Acad Child Adolesc Psychiatry; 1991 Jan; 30(1):154-5. PubMed ID: 2005055
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug treatment of obsessive-compulsive disorders--a comparative study of the effectiveness of clomipramine and fluoxetine].
    Volk S
    Fortschr Neurol Psychiatr; 1995 Jun; 63 Suppl 1():28-32. PubMed ID: 7635392
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluoxetine in obsessive compulsive disorder in adolescents.
    Bouvard M; Dugas M
    Int Clin Psychopharmacol; 1993; 8(4):307-10. PubMed ID: 8277152
    [No Abstract]   [Full Text] [Related]  

  • 18. Hair loss associated with fluoxetine treatment.
    Ananth J; Elmishaugh A
    Can J Psychiatry; 1991 Oct; 36(8):621. PubMed ID: 1742721
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B; Bonnet-Perrin E
    Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term fluoxetine treatment of a large number of obsessive-compulsive patients.
    Levine R; Hoffman JS; Knepple ED; Kenin M
    J Clin Psychopharmacol; 1989 Aug; 9(4):281-3. PubMed ID: 2504781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.